New cases tested for RR-/MDR-TB (%) in China
China: New cases tested for RR-/MDR-TB was 91.0% in 2024. ◆ Volatile
New cases tested for RR-/MDR-TB in China, 2006–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, new cases tested for rr-/mdr-tb in China stood at 91.0%. That is the highest value across all 16 years on record.
Compared with earlier readings it is up 2.2% on the previous year and up 378.9% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in China peaked at 91.0% in 2024 and was at its lowest, 0.0%, in 2006.
China ranks 91st of 192 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
New cases tested for RR-/MDR-TB in China, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 0.0% | — |
| 2007 | 0.1% | — |
| 2011 | 2.6% | +2500.0% |
| 2012 | 4.3% | +65.4% |
| 2013 | 11.0% | +155.8% |
| 2014 | 19.0% | +72.7% |
| 2015 | 29.0% | +52.6% |
| 2016 | 46.0% | +58.6% |
| 2017 | 42.0% | -8.7% |
| 2018 | 58.0% | +38.1% |
| 2019 | 80.0% | +37.9% |
| 2020 | 83.0% | +3.8% |
| 2021 | 80.0% | -3.6% |
| 2022 | 86.0% | +7.5% |
| 2023 | 89.0% | +3.5% |
| 2024 | 91.0% | +2.2% |
China compared with similar countries
- China's 91.0% is below the median for upper middle income countries, which is 92.0%, 99% of the median. (57 countries reporting)
- China's 91.0% is below the median for East Asia & Pacific, which is 94.0%, 97% of the median. (31 countries reporting)
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in China changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +2500.0% | 0.1% | 2.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.1% | 0.0% | 0.1% | 2 |
| 2010s | 32.4% | 2.6% | 80.0% | 9 |
| 2020s | 85.8% | 80.0% | 91.0% | 5 |
Countries ranked near China
- 91 Uruguay 91.0% compare
- 91 Netherlands 91.0% compare
- 91 United States 91.0% compare
- 91 Myanmar 91.0% compare
- 91 Libya 91.0% compare
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 10 (2025)
- Population ages 00-04, female, annual growth rate -8.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0159 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in China?
- New cases tested for rr-/mdr-tb in China was 91.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in China?
- The highest recorded value was 91.0% in 2024.
- What is the lowest new cases tested for rr-/mdr-tb recorded in China?
- The lowest recorded value was 0.0% in 2006.
- How does China rank for new cases tested for rr-/mdr-tb?
- China ranks 91st out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in China?
- Over the last ten years it is up 378.9%. The long-run trend across the full record is volatile.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).